,Date,News Headline,Article Link,Source
0,2022-03-02 08:38,Why Earnings Season Could Be Great for Mirum Pharmaceuticals (MIRM),https://finance.yahoo.com/news/why-earnings-season-could-great-133801014.html,Zacks
1,2022-03-02 08:30,"Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End Business Results for 2021 and Host Conference Call on March 9, 2022",https://finance.yahoo.com/news/mirum-pharmaceuticals-announce-fourth-quarter-133000573.html,Business Wire
2,2022-02-17 09:27,Mirum Pharmaceuticals' (NASDAQ:MIRM) investors will be pleased with their 14% return over the last year,https://finance.yahoo.com/news/mirum-pharmaceuticals-nasdaq-mirm-investors-142718348.html,Simply Wall St.
3,2022-02-10 19:00,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-000000890.html,Business Wire
4,2022-02-09 08:30,Mirum Pharmaceuticals to Present at SVB Leerink 11th Annual Global Healthcare Conference,https://finance.yahoo.com/news/mirum-pharmaceuticals-present-svb-leerink-133000423.html,Business Wire
5,2022-01-14 09:38,"Mesirow Financial Investment Management, Inc. ...",https://finance.yahoo.com/news/mesirow-financial-investment-management-inc-143810439.html,GuruFocus.com
6,2022-01-11 08:00,Mirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate Milestones,https://finance.yahoo.com/news/mirum-pharmaceuticals-provides-business-highlights-130000513.html,Business Wire
7,2022-01-10 20:30,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-013000002.html,Business Wire
8,2022-01-04 08:30,"Mirum Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022",https://finance.yahoo.com/news/mirum-pharmaceuticals-present-40th-annual-133000180.html,Business Wire
9,2021-12-15 08:30,Mirum Pharmaceuticals Added to NASDAQ Biotechnology Index,https://finance.yahoo.com/news/mirum-pharmaceuticals-added-nasdaq-biotechnology-133000348.html,Business Wire
10,2021-12-13 08:30,LIVMARLI (maralixibat) Presentations Show Improvements in Quality of Life Measures in Alagille Syndrome and PFIC2 at NASPGHAN Annual Meeting 2021,https://finance.yahoo.com/news/livmarli-maralixibat-presentations-show-improvements-133000659.html,Business Wire
11,2021-12-06 08:30,Mirum Pharmaceuticals to Present LIVMARLI (maralixibat) Analyses at NASPGHAN 2021 Annual Meeting,https://finance.yahoo.com/news/mirum-pharmaceuticals-present-livmarli-maralixibat-133000446.html,Business Wire
12,2021-12-01 05:03,"The President of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), Christopher Peetz, Just Bought 3.3% More Shares",https://finance.yahoo.com/news/president-mirum-pharmaceuticals-inc-nasdaq-100357326.html,Simply Wall St.
13,2021-11-30 11:53,"Moore Kuehn, PLLC Encourages Investors of Mirum Pharmaceuticals, Inc. to Contact Law Firm",https://finance.yahoo.com/news/moore-kuehn-pllc-encourages-investors-165300039.html,Newsfile
14,2021-11-22 08:30,Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences,https://finance.yahoo.com/news/mirum-pharmaceuticals-participate-upcoming-investor-133000635.html,Business Wire
15,2021-11-17 08:30,Mirum Pharmaceuticals Sells Rare Pediatric Disease Priority Review Voucher,https://finance.yahoo.com/news/mirum-pharmaceuticals-sells-rare-pediatric-133000652.html,Business Wire
16,2021-11-15 17:25,"Mirum Pharmaceuticals, Inc. (MIRM) Reports Q3 Loss",https://finance.yahoo.com/news/mirum-pharmaceuticals-inc-mirm-reports-222510037.html,Zacks
17,2021-11-15 16:01,Mirum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update,https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-third-quarter-210100353.html,Business Wire
18,2021-11-15 12:30,Six-Year Natural History Comparison with Mirums LIVMARLI (maralixibat) Demonstrates Event-Free Survival and Transplant-Free Survival in Patients with Alagille Syndrome,https://finance.yahoo.com/news/six-natural-history-comparison-mirum-173000652.html,Business Wire
19,2021-11-08 16:05,"Mirum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference Call on November 15, 2021",https://finance.yahoo.com/news/mirum-pharmaceuticals-report-third-quarter-210500722.html,Business Wire
20,2021-11-01 13:12,New LIVMARLI (maralixibat) Data to be Showcased at AASLD The Liver MeetingÂ® 2021,https://finance.yahoo.com/news/livmarli-maralixibat-data-showcased-aasld-171200280.html,Business Wire
21,2021-11-01 08:30,The Lancet Publishes Data From Mirum Pharmaceuticals' ICONIC Pivotal Study of Maralixibat (LIVMARLI) Treatment in Alagille Syndrome,https://finance.yahoo.com/news/lancet-publishes-data-mirum-pharmaceuticals-123000158.html,Business Wire
22,2021-09-29 17:45,How a miserable itch sent a young company to its first drug approval for a deadly disease,https://www.bizjournals.com/sanfrancisco/news/2021/09/29/mirum-alagille-syndrome-itch-maralixibat-livmarli.html?ana=yahoo,American City Business Journals
23,2021-09-29 13:19,UPDATE 3-Mirum's oral drug becomes first U.S. approved Alagille syndrome therapy,https://finance.yahoo.com/news/1-mirum-pharmas-treatment-rare-171924347.html,Reuters
24,2021-09-29 13:00,U.S. FDA Approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome One Year of Age and Older,https://finance.yahoo.com/news/u-fda-approves-livmarli-maralixibat-170000429.html,Business Wire
25,2021-09-22 08:55,Mirum (MIRM)-Takeda Collaborate for Liver Disease Drug in Japan,https://finance.yahoo.com/news/mirum-mirm-takeda-collaborate-liver-125512863.html,Zacks
26,2021-09-21 11:00,"Mirum, Takeda Ink Maralixibat Licensing Pact In Japan",https://finance.yahoo.com/news/mirum-takeda-ink-maralixibat-licensing-150033946.html,Benzinga
27,2021-09-21 08:00,Mirum Pharmaceuticals and Takeda Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan,https://finance.yahoo.com/news/mirum-pharmaceuticals-takeda-enter-exclusive-120000470.html,Business Wire
28,2021-09-13 06:45,Mirum Pharmaceuticals Submits European Marketing Authorization Application for Maralixibat in Alagille Syndrome Supported by New Positive Results from Natural History Study Comparison,https://finance.yahoo.com/news/mirum-pharmaceuticals-submits-european-marketing-104500991.html,Business Wire
29,2021-09-10 17:30,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-213000432.html,Business Wire
30,2021-09-02 17:30,Mirum Pharmaceuticals to Participate in September Investor Conferences,https://finance.yahoo.com/news/mirum-pharmaceuticals-participate-september-investor-213000931.html,Business Wire
31,2021-08-26 08:53,The past year for Mirum Pharmaceuticals (NASDAQ:MIRM) investors has not been profitable,https://finance.yahoo.com/news/past-mirum-pharmaceuticals-nasdaq-mirm-125329242.html,Simply Wall St.
32,2021-08-19 17:30,Mirum Pharmaceuticals Appoints Biotechnology Executive William C. Fairey to its Board of Directors,https://finance.yahoo.com/news/mirum-pharmaceuticals-appoints-biotechnology-executive-213000225.html,Business Wire
33,2021-08-10 19:00,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-230000553.html,Business Wire
34,2021-08-05 18:35,"Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Misses Revenue Estimates",https://finance.yahoo.com/news/mirum-pharmaceuticals-inc-mirm-reports-223510831.html,Zacks
35,2021-08-05 16:02,Mirum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update,https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-second-quarter-200200999.html,Business Wire
36,2021-07-29 16:00,"Mirum Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021",https://finance.yahoo.com/news/mirum-pharmaceuticals-report-second-quarter-200000451.html,Business Wire
37,2021-07-27 06:59,Mirum Pharma Out-Licenses Maralixibat Rights To GC Pharma in South Korea,https://finance.yahoo.com/news/mirum-pharma-licenses-maralixibat-rights-105954126.html,Benzinga
38,2021-07-26 20:00,Mirum Pharmaceuticals and GC Pharma Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Liver Diseases in South Korea,https://finance.yahoo.com/news/mirum-pharmaceuticals-gc-pharma-enter-000000556.html,Business Wire
39,2021-07-12 18:00,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-220000074.html,Business Wire
40,2021-07-12 05:41,"What You Need To Know About Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Investor Composition",https://finance.yahoo.com/news/know-mirum-pharmaceuticals-inc-nasdaq-094104529.html,Simply Wall St.
41,2021-06-24 16:05,Mirum Pharmaceuticals to Present at Piper Sandlers Virtual EASL Takeaway Day,https://finance.yahoo.com/news/mirum-pharmaceuticals-present-piper-sandler-200500459.html,Business Wire
42,2021-06-23 09:00,Mirum Pharmaceuticals Presents Analyses From Its Rare Liver Disease Programs at the EASL International Liver Congress 2021,https://finance.yahoo.com/news/mirum-pharmaceuticals-presents-analyses-rare-130000818.html,Business Wire
43,2021-06-16 09:00,Mirum Pharmaceuticals to Showcase Analyses From Its Rare Liver Disease Programs at The International Liver Congress 2021,https://finance.yahoo.com/news/mirum-pharmaceuticals-showcase-analyses-rare-130000035.html,Business Wire
44,2021-06-10 17:30,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-213000087.html,Business Wire
45,2021-06-07 09:00,"Mirum Pharmaceuticals Appoints Veteran Biotechnology Executive Carol L. Brosgart, M.D. to Board of Directors",https://finance.yahoo.com/news/mirum-pharmaceuticals-appoints-veteran-biotechnology-130000613.html,Business Wire
46,2021-06-03 10:10,Mirum Pharmaceuticals Showcases Maralixibat Transplant-Free Survival Data for Progressive Familial Intrahepatic Cholestasis and Long-Term Safety Analyses for Alagille Syndrome during WCPGHAN Annual Meeting,https://finance.yahoo.com/news/mirum-pharmaceuticals-showcases-maralixibat-transplant-141000744.html,Business Wire
47,2021-05-26 09:00,"Mirum Pharmaceuticals to Present Maralixibat Data and Host Symposium at the 6th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition (WCPGHAN) Annual Meeting 2021",https://finance.yahoo.com/news/mirum-pharmaceuticals-present-maralixibat-data-130000361.html,Business Wire
48,2021-05-12 04:47,We're Not Very Worried About Mirum Pharmaceuticals' (NASDAQ:MIRM) Cash Burn Rate,https://finance.yahoo.com/news/were-not-very-worried-mirum-084706585.html,Simply Wall St.
49,2021-05-10 21:00,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-010000453.html,Business Wire
50,2021-05-06 19:50,"Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Lags Revenue Estimates",https://finance.yahoo.com/news/mirum-pharmaceuticals-inc-mirm-reports-235011463.html,Zacks
51,2021-05-06 16:05,Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update,https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-first-quarter-200500437.html,Business Wire
52,2021-05-06 14:30,Mirum Pharmaceuticals Inc to Host Earnings Call,https://finance.yahoo.com/news/mirum-pharmaceuticals-inc-host-earnings-183000960.html,ACCESSWIRE
53,2021-04-29 16:05,"Mirum Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call on May 6, 2021",https://finance.yahoo.com/news/mirum-pharmaceuticals-report-first-quarter-200500475.html,Business Wire
54,2021-04-29 08:00,Mirum Pharmaceuticals and CANbridge Pharmaceuticals Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat in Greater China for Rare Liver Diseases,https://finance.yahoo.com/news/mirum-pharmaceuticals-canbridge-pharmaceuticals-enter-120000980.html,Business Wire
55,2021-04-26 09:00,Mirum Pharmaceuticals Receives Notice of Allowance for Methods of Use Patent for Maralixibat in Alagille Syndrome,https://finance.yahoo.com/news/mirum-pharmaceuticals-receives-notice-allowance-130000758.html,Business Wire
56,2021-04-12 17:30,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-213000650.html,Business Wire
57,2021-04-12 08:00,Mirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and License Agreement for Vivets Gene Therapy Programs Targeting Progressive Familial Intrahepatic Cholestasis,https://finance.yahoo.com/news/mirum-pharmaceuticals-vivet-therapeutics-enter-120000543.html,Business Wire
58,2021-03-29 09:00,Mirum Pharmaceuticals Announces FDA Acceptance of New Drug Application and Priority Review for Maralixibat in Alagille Syndrome,https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-fda-acceptance-130000431.html,Business Wire
59,2021-03-13 03:39,"Have Insiders Been Buying Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares?",https://finance.yahoo.com/news/insiders-buying-mirum-pharmaceuticals-inc-083933287.html,Simply Wall St.
60,2021-03-10 18:00,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-230000974.html,Business Wire
61,2021-03-09 17:25,"Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Lags Revenue Estimates",https://finance.yahoo.com/news/mirum-pharmaceuticals-inc-mirm-reports-222510811.html,Zacks
62,2021-03-09 16:02,Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Results and Provides Business Updates,https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-fourth-quarter-210200273.html,Business Wire
63,2021-03-09 09:09,Why Earnings Season Could Be Great for Mirum Pharmaceuticals (MIRM),https://finance.yahoo.com/news/why-earnings-season-could-great-140902701.html,Zacks
64,2021-02-22 09:00,Mirum Pharmaceuticals to Present at Upcoming Investor Conferences,https://finance.yahoo.com/news/mirum-pharmaceuticals-present-upcoming-investor-140000319.html,Business Wire
65,2021-02-10 17:30,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-223000692.html,Business Wire
66,2021-02-08 10:12,"Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2021",https://finance.yahoo.com/news/benzingas-top-ratings-upgrades-downgrades-151231622.html,Benzinga
67,2021-02-01 09:00,Mirum Pharmaceuticals Announces Completion of Rolling NDA Submission for Maralixibat in Alagille Syndrome,https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-completion-rolling-140000814.html,Business Wire
68,2021-01-24 09:00,Mirum Pharmaceuticals Honors Alagille Syndrome Awareness Day with Launch of Disease Awareness Campaign,https://finance.yahoo.com/news/mirum-pharmaceuticals-honors-alagille-syndrome-140000705.html,Business Wire
69,2021-01-14 09:00,Mirum Pharmaceuticals Announces First Patient Enrolled in Phase 2b VISTAS Clinical Study Evaluating Volixibat in Adult Patients With Primary Sclerosing Cholangitis,https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-first-patient-140000184.html,Business Wire
70,2021-01-12 09:00,Mirum Pharmaceuticals Provides Corporate Update,https://finance.yahoo.com/news/mirum-pharmaceuticals-provides-corporate-140000826.html,Business Wire
71,2021-01-08 18:17,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-231700541.html,Business Wire
72,2021-01-04 08:30,"Mirum Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021",https://finance.yahoo.com/news/mirum-pharmaceuticals-present-39th-annual-133000227.html,Business Wire
73,2020-12-30 02:45,"What Kind Of Shareholders Own Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)?",https://finance.yahoo.com/news/kind-shareholders-own-mirum-pharmaceuticals-074559607.html,Simply Wall St.
74,2020-12-22 08:55,Mirum Pharmaceuticals (MIRM) in Focus: Stock Moves 5.9% Higher,https://finance.yahoo.com/news/mirum-pharmaceuticals-mirm-focus-stock-135501708.html,Zacks
75,2020-12-14 21:00,Mirum Pharmaceuticals Announces Pricing of Public Offering of Common Stock,https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-pricing-public-020000021.html,Business Wire
76,2020-12-14 07:00,Mirum Pharmaceuticals Announces Commencement of Public Offering of Common Stock,https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-commencement-public-120000248.html,Business Wire
77,2020-12-10 22:33,Is MIRM A Good Stock To Buy Now?,https://finance.yahoo.com/news/mirm-good-stock-buy-now-033328165.html,Insider Monkey
78,2020-12-10 19:41,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-004100137.html,Business Wire
79,2020-12-09 09:00,Mirum Pharmaceuticals and Oberland Capital Announce Up to $210 Million Funding Arrangement,https://finance.yahoo.com/news/mirum-pharmaceuticals-oberland-capital-announce-140000071.html,Business Wire
80,2020-12-07 09:00,Mirum Pharmaceuticals Announces Virtual Investor Day 2020,https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-virtual-investor-140000617.html,Business Wire
81,2020-11-30 08:30,Mirum Pharmaceuticals Announces European Medicines Agency Validation of the Marketing Authorization Application for Maralixibat in Patients with PFIC2,https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-european-medicines-133000038.html,Business Wire
82,2020-11-23 09:30,Mirum Pharmaceuticals to Present at Upcoming Investor Conferences,https://finance.yahoo.com/news/mirum-pharmaceuticals-present-upcoming-investor-143000359.html,Business Wire
83,2020-11-15 18:00,Mirum Pharmaceuticals Announces Data Presented During AASLD Highlighting Durable Improvements in Pruritus and Quality of Life in Children with Alagille Syndrome Treated with Maralixibat,https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-data-presented-230000141.html,Business Wire
84,2020-11-13 08:10,Mirum Pharmaceuticals Presents New Data From Its Maralixibat and Volixibat Clinical Studies at AASLD Annual Meeting,https://finance.yahoo.com/news/mirum-pharmaceuticals-presents-data-maralixibat-131000099.html,Business Wire
85,2020-11-12 09:00,"Mirum Pharmaceuticals Provides Third Quarter 2020 Financial Results and Business Update, and Announces Virtual Investor Day",https://finance.yahoo.com/news/mirum-pharmaceuticals-provides-third-quarter-140000172.html,Business Wire
86,2020-11-10 19:00,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-000000656.html,Business Wire
87,2020-11-05 08:30,Mirum Pharmaceuticals Broadens Expanded Access Program for Maralixibat in Alagille Syndrome to Europe and Australia,https://finance.yahoo.com/news/mirum-pharmaceuticals-broadens-expanded-access-133000071.html,Business Wire
88,2020-11-02 08:30,Mirum Pharmaceuticals Announces New Data Being Presented in Late-Breaker Oral and Poster Presentations at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD),https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-data-being-133000608.html,Business Wire
89,2020-10-26 08:30,Mirum Pharmaceuticals to Present Maralixibat Data and Host Symposium at the NASPGHAN Annual Meeting 2020,https://finance.yahoo.com/news/mirum-pharmaceuticals-present-maralixibat-data-123000131.html,Business Wire
90,2020-10-15 08:55,Mirum Pharmaceuticals Announces Partnership With EVERSANA to Support Launch and Commercialization of Maralixibat for Alagille Syndrome in the United States,https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-partnership-eversana-125500844.html,PR Newswire
91,2020-10-15 08:45,Mirum Pharmaceuticals Announces Partnership With EVERSANA to Support Launch and Commercialization of Maralixibat for Alagille Syndrome in the United States,https://finance.yahoo.com/news/mirum-pharmaceuticals-announces-partnership-eversana-124500983.html,Business Wire
92,2020-10-14 10:29,Raymond James Says These 3 Stocks Could Surge Over 100% From Current Levels,https://finance.yahoo.com/news/raymond-james-says-3-stocks-142911359.html,TipRanks
93,2020-10-13 16:05,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-200500176.html,Business Wire
94,2020-09-11 16:30,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-203000034.html,Business Wire
95,2020-09-11 07:00,Mirum Pharmaceuticals to Present at Investor Conferences in September,https://finance.yahoo.com/news/mirum-pharmaceuticals-present-investor-conferences-110000232.html,Business Wire
96,2020-09-01 09:00,Mirum Pharmaceuticals Initiates Rolling Submission of a New Drug Application for Maralixibat for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome and Launches Expanded Access Program,https://finance.yahoo.com/news/mirum-pharmaceuticals-initiates-rolling-submission-130000426.html,Business Wire
97,2020-08-29 08:45,Mirum Pharmaceuticals Presents Maralixibat Five-Year Transplant-Free Survival Data for Patients With PFIC2 at Digital International Liver Congress 2020,https://finance.yahoo.com/news/mirum-pharmaceuticals-presents-maralixibat-five-124500939.html,Business Wire
98,2020-08-11 17:30,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-inducement-grants-213000997.html,Business Wire
99,2020-08-11 09:42,We're Hopeful That Mirum Pharmaceuticals (NASDAQ:MIRM) Will Use Its Cash Wisely,https://finance.yahoo.com/news/were-hopeful-mirum-pharmaceuticals-nasdaq-134235856.html,Simply Wall St.
